BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28781158)

  • 1. Nitro-substituted tetrahydroindolizines and homologs: Design, kinetics, and mechanism of α-glucosidase inhibition.
    Tavani C; Bianchi L; De Palma A; Passeri GI; Punzi G; Pierri CL; Lovece A; Cavalluzzi MM; Franchini C; Lentini G; Petrillo G
    Bioorg Med Chem Lett; 2017 Sep; 27(17):3980-3986. PubMed ID: 28781158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li J; Li X
    Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
    Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
    Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors.
    Wang G; Wang J; He D; Li X; Li J; Peng Z
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2806-2809. PubMed ID: 27177827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors.
    Wang G; He D; Li X; Li J; Peng Z
    Bioorg Chem; 2016 Apr; 65():167-74. PubMed ID: 26964016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular docking studies and synthesis of novel bisbenzimidazole derivatives as inhibitors of α-glucosidase.
    Özil M; Emirik M; Beldüz A; Ülker S
    Bioorg Med Chem; 2016 Nov; 24(21):5103-5114. PubMed ID: 27576293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
    Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
    Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel flavonoid alkaloids as α-glucosidase inhibitors.
    Zhen J; Dai Y; Villani T; Giurleo D; Simon JE; Wu Q
    Bioorg Med Chem; 2017 Oct; 25(20):5355-5364. PubMed ID: 28797772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory activity evaluation and mechanistic studies of tetracyclic oxindole derivatives as α-glucosidase inhibitors.
    Sun H; Zhang Y; Ding W; Zhao X; Song X; Wang D; Li Y; Han K; Yang Y; Ma Y; Wang R; Wang D; Yu P
    Eur J Med Chem; 2016 Nov; 123():365-378. PubMed ID: 27487567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel oxazolxanthone derivatives as a new type of α-glucosidase inhibitor: synthesis, activities, inhibitory modes and synergetic effect.
    Ding SM; Lan T; Ye GJ; Huang JJ; Hu Y; Zhu YR; Wang B
    Bioorg Med Chem; 2018 Jul; 26(12):3370-3378. PubMed ID: 29776833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.
    Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M
    Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of potent α-glucosidase inhibitor flavonols: Insights into mechanism of action through inhibition kinetics and docking simulations.
    Şöhretoğlu D; Sari S; Barut B; Özel A
    Bioorg Chem; 2018 Sep; 79():257-264. PubMed ID: 29778797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors.
    Han K; Li Y; Zhang Y; Teng Y; Ma Y; Wang M; Wang R; Xu W; Yao Q; Zhang Y; Qin H; Sun H; Yu P
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1471-5. PubMed ID: 25759031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, semisynthesis, α-glucosidase inhibitory, cytotoxic, and antibacterial activities of p-terphenyl derivatives.
    Zhang XQ; Mou XF; Mao N; Hao JJ; Liu M; Zheng JY; Wang CY; Gu YC; Shao CL
    Eur J Med Chem; 2018 Feb; 146():232-244. PubMed ID: 29407953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
    Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors.
    Asemanipoor N; Mohammadi-Khanaposhtani M; Moradi S; Vahidi M; Asadi M; Faramarzi MA; Mahdavi M; Biglar M; Larijani B; Hamedifar H; Hajimiri MH
    Bioorg Chem; 2020 Jan; 95():103482. PubMed ID: 31838286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li X; Li J
    Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors.
    Wang G; Wang J; He D; Li X; Li J; Peng Z
    Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hetarylcoumarins: Synthesis and biological evaluation as potent α-glucosidase inhibitors.
    Chaudhry F; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Munir R; Sohail R; Jahan B; Munawar MA; Khan MA
    Bioorg Chem; 2017 Aug; 73():1-9. PubMed ID: 28521172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, α-glucosidase inhibitory, cytotoxicity and docking studies of 2-aryl-7-methylbenzimidazoles.
    Taha M; Ismail NH; Imran S; Mohamad MH; Wadood A; Rahim F; Saad SM; Rehman AU; Khan KM
    Bioorg Chem; 2016 Apr; 65():100-9. PubMed ID: 26894559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.